Fidelis Capital Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Buy
15,270
+490
+3% +$110K 0.23% 87
2025
Q4
$2.53M Buy
14,780
+577
+4% +$89.7K 0.18% 101
2025
Q3
$1.9M Buy
14,203
+136
+1% +$14.4K 0.15% 118
2025
Q2
$1.35M Buy
14,067
+493
+4% +$39.1K 0.12% 137
2025
Q1
$969K Buy
13,574
+97
+0.7% +$7.64K 0.1% 161
2024
Q4
$1.08M Sell
13,477
-127,893
-90% -$9.7M 0.11% 157
2024
Q3
$1.03M Buy
141,370
+117,310
+488% +$10.2M 0.12% 148
2024
Q2
$1.8M Buy
24,060
+4,490
+23% +$431K 0.26% 77
2024
Q1
$1.9M Buy
19,570
+7,310
+60% +$643K 0.29% 69
2023
Q4
$960K Buy
12,260
+1,120
+10% +$76.3K 0.21% 97
2023
Q3
$698K Buy
11,140
+1,210
+12% +$79.5K 0.24% 100
2023
Q2
$638K Buy
9,930
+460
+5% +$25.9K 0.23% 105
2023
Q1
$502K Buy
+9,470
New +$465K 0.21% 117

Other funds holding LRCX

Fidelis Capital Partners's LRCX Position: Q1 2026 in Review

Fidelis Capital Partners increased its Lam Research (LRCX) stake by 3.3% in Q1 2026, buying an estimated $110K and bringing the position to 15,270 shares worth $3.26M. The position accounts for 0.23% of the portfolio, ranked #87.

Fidelis Capital Partners first reported a position in LRCX in Q1 2023 and has held it in 13 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Fidelis Capital Partners held 15,270 shares of Lam Research worth $3.26M as of Q1 2026.
  • Fidelis Capital Partners bought 490 Lam Research shares in Q1 2026, an estimated $110K.
  • Lam Research made up 0.23% of Fidelis Capital Partners's portfolio in Q1 2026, its #87 holding.
  • Fidelis Capital Partners first reported a position in Lam Research in Q1 2023 and has held it in 13 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.